CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain

A trinucleotide repeat (CAG) expansion in the huntingtin gene causes Huntington's disease (HD). In brain tissue from HD heterozygotes with adult onset and more clinically severe juvenile onset, where the largest expansions occur, a mutant protein of equivalent intensity to wild-type huntingtin was detected in cortical synaptosomes, indicating that a mutant species is synthesized and transported with the normal protein to nerve endings. The increased size of mutant huntingtin relative to the wild type was highly correlated with CAG repeat expansion, thereby linking an altered electrophoretic mobility of the mutant protein to its abnormal function. Mutant huntingtin appeared in gray and white matter with no difference in expression in affected regions. The mutant protein was broader than the wild type and in 6 of 11 juvenile cases resolved as a complex of bands, consistent with evidence at the DNA level for somatic mosaicism. Thus, HD pathogenesis results from a gain of function by an aberrant protein that is widely expressed in brain and is harmful only to some neurons.

[1]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[2]  I. Kanazawa,et al.  Abnormal gene product identified in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) brain , 1995, Nature Genetics.

[3]  P. Willems Dynamic mutations hit double figures , 1994, Nature Genetics.

[4]  H. Koenig The isolation of lysosomes from brain. , 1974, Methods in enzymology.

[5]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[6]  A. Young Huntington's Disease: Lessons from and for Molecular Neuroscience , 1995 .

[7]  M. Tabaton,et al.  Ubiquitin-reactive neurites in cerebral cortex of subjects with Huntington's chorea: a pathological correlate of dementia? , 1993, Neuroscience Letters.

[8]  H. Zoghbi,et al.  Expression analysis of the ataxin–1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals , 1995, Nature Genetics.

[9]  M. Hayden,et al.  Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm , 1994, Nature Genetics.

[10]  E. Hirsch,et al.  Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form , 1995, Nature Genetics.

[11]  M. Hayden,et al.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.

[12]  M. MacDonald,et al.  Gametic but not somatic instability of CAG repeat length in Huntington's disease. , 1993, Journal of medical genetics.

[13]  H. Lange,et al.  Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. , 1993, Human molecular genetics.

[14]  Charles B. Dunlap PATHOLOGIC CHANGES IN HUNTINGTON'S CHOREA: WITH SPECIAL REFERENCE TO THE CORPUS STRIATUM , 1927 .

[15]  S. Folstein Huntington's disease : a disorder of families , 1989 .

[16]  A. Joyner,et al.  Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.

[17]  S. Floresco,et al.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.

[18]  C A Ross,et al.  Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. , 1993, Human molecular genetics.

[19]  Christopher A Ross,et al.  Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.

[20]  H. Zoghbi,et al.  Gametic and somatic tissue–specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1 , 1995, Nature Genetics.

[21]  J. Vonsattel,et al.  Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.

[22]  J. Penney,et al.  Homozygotes for Huntington's disease , 1987, Nature.

[23]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. MacDonald,et al.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease , 1993, Nature Genetics.

[25]  R. Carraway,et al.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.

[26]  H. Lehrach,et al.  Trinucleotide repeat expansions and human genetic disease. , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[27]  C. Ross,et al.  Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients. , 1995, Human molecular genetics.

[28]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[29]  F. Hazama,et al.  Somatic mosaicism of CAG repeat in dentatorubral-pallidoluysian atrophy (DRPLA). , 1995, Human molecular genetics.

[30]  S. Rogers,et al.  Microinjection of ubiquitin: changes in protein degradation in HeLa cells subjected to heat-shock , 1987, The Journal of cell biology.

[31]  I. Kanazawa,et al.  Abnormal gene product identified in Huntington's disease lymphocytes and brain. , 1995, Biochemical and biophysical research communications.

[32]  S. Colowick,et al.  Methods in Enzymology , Vol , 1966 .

[33]  M. Hayden,et al.  A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington disease. , 1993, Human molecular genetics.

[34]  Yasuo Ihara,et al.  Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.